These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35437206)

  • 1. Immunogenicity of varicella-zoster virus vaccine by different routes of administration: Comparable vaccination efficacy of one-fifth dose intradermal vaccination to conventional subcutaneous vaccination.
    Nakamura-Nishimura Y; Shinkuma S; Miyagawa F; Haredy A; Gomi Y; Yamanishi K; Asada H
    J Dermatol Sci; 2022 May; 106(2):86-92. PubMed ID: 35437206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial.
    Beals CR; Railkar RA; Schaeffer AK; Levin Y; Kochba E; Meyer BK; Evans RK; Sheldon EA; Lasseter K; Lang N; Weinberg A; Canniff J; Levin MJ
    Lancet Infect Dis; 2016 Aug; 16(8):915-22. PubMed ID: 27061887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
    Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
    Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P;
    Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM; Andriolo BN; Torloni MR; Soares BG
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008858. PubMed ID: 26937872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, and Humoral and Cell-mediated Immune Responses to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis.
    Koh JH; Lee J; Kim SH; Kwok SK; Ju JH; Park SH
    J Rheumatol; 2018 Apr; 45(4):465-469. PubMed ID: 29419465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
    Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
    Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inactivated herpes zoster vaccine HZ/su induces a varicella zoster virus specific cellular and humoral immune response in patients on dialysis.
    Hielscher F; Schmidt T; Enders M; Leyking S; Gerhart M; van Bentum K; Mihm J; Schub D; Sester U; Sester M
    EBioMedicine; 2024 Oct; 108():105335. PubMed ID: 39265505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella Virus Vaccination in the United States.
    Shaw J; Gershon AA
    Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.
    Perciani CT; Jaoko W; Walmsley S; Farah B; Mahmud SM; Ostrowski M; Anzala O; Team KI; MacDonald KS
    BMJ Open; 2017 Sep; 7(9):e017391. PubMed ID: 28939581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies.
    Parrino J; McNeil SA; Lawrence SJ; Kimby E; Pagnoni MF; Stek JE; Zhao Y; Chan IS; Kaplan SS
    Vaccine; 2017 Mar; 35(14):1764-1769. PubMed ID: 28268074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibility of prevention of herpes zoster by use of varicella vaccine].
    Kawano S; Terada K; Yagi Y; Kataoka N
    Kansenshogaku Zasshi; 1998 Jul; 72(7):714-9. PubMed ID: 9745221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella and herpes zoster vaccine development: lessons learned.
    Warren-Gash C; Forbes H; Breuer J
    Expert Rev Vaccines; 2017 Dec; 16(12):1191-1201. PubMed ID: 29047317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
    Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.
    Laing KJ; Russell RM; Dong L; Schmid DS; Stern M; Magaret A; Haas JG; Johnston C; Wald A; Koelle DM
    J Infect Dis; 2015 Oct; 212(7):1022-31. PubMed ID: 25784732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial.
    Hata A; Inoue F; Hamamoto Y; Yamasaki M; Fujikawa J; Kawahara H; Kawasaki Y; Honjo S; Koshiyama H; Moriishi E; Mori Y; Ohkubo T
    Diabet Med; 2016 Aug; 33(8):1094-101. PubMed ID: 26605507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults.
    Macaladad N; Marcano T; Guzman M; Moya J; Jurado F; Thompson M; Meechan C; Li D; Schlienger K; Chan I; Sadoff J; Schödel F; Silber JL
    Vaccine; 2007 Mar; 25(11):2139-44. PubMed ID: 17250932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
    Levin MJ; Buchwald UK; Gardner J; Martin J; Stek JE; Brown E; Popmihajlov Z
    Vaccine; 2018 Jan; 36(1):179-185. PubMed ID: 28830693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.